Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |